Biosante Pharmaceuticals Aktie
54,50
EUR
±0,00
EUR
±0,00
%
58,65
USD
+0,07
USD
+0,12
%
Werbung
Biosante Pharmaceuticals Aktie Analyse
24.05.16 | Biosante Pharmaceuticals Hold | Standpoint Research | |
04.08.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
15.07.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
18.05.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
10.04.15 | Biosante Pharmaceuticals Neutral | ROTH Capital Partners, LLC |
Werbung
Werbung